Area of research
Oncology · Molecular Biology
Research interest
Research interests include Cancer research, Biology, Ovarian cancer, Immune system, Innate immune system, and Olaparib.
STING agonism overcomes STAT3-mediated immunosuppression and adaptive resistance to PARP inhibition in ovarian cancer
STING agonism reprograms tumor-associated macrophages and overcomes resistance to PARP inhibition in BRCA1-deficient models of breast cancer
EZH2 cooperates with gain‐of‐function p53 mutants to promote cancer growth and metastasis
PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian Cancer
Regulation of cell cycle of hepatocellular carcinoma by NF90 through modulation of cyclin E1 mRNA stability